Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Mclazide-M Tablet

Prescription Icon
Prescription Required

Marketer

Mitoch Pharma Pvt Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Mclazide-M Tablet

Diabexe Duo tablets are a dual-action antidiabetic medication used in adult patients with type 2 diabetes. This combination therapy helps regulate blood glucose. Diabexe Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, it’s part of a comprehensive approach including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Carry a fast-acting glucose source (e.g., sugary snacks or juice) to counter hypoglycemia. Alcohol intake increases hypoglycemia risk and should be limited. Other possible side effects are altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Inform your doctor about any history of heart disease before starting treatment, as it may be unsuitable. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring is essential; additional blood tests may be recommended to track blood cell counts and liver function.

Primary Ingredients of Mclazide-M Tablet

The provided text is "undefined," offering no content to rephrase.

Uses of Mclazide-M Tablet

Adult-onset diabetes

Major Benefits of Mclazide-M Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mclazide-M should be administered with a meal.

Common Side effects of Mclazide-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Mclazide-M Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mclazide-M tablets should be administered with a meal.

How Mclazide-M Tablet works:

Gliclazide and metformin are combined in Mclazide-M tablets to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Mclazide-M Tablet and alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Mclazide-M tablets during pregnancy poses a known risk to the fetus. Therefore, its use is inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the risks. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Nursing mothers should likely avoid Mclazide-M tablets. Available evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Mclazide-M tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Mclazide-M use. Physician consultation is recommended. Routine monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Mclazide-M Tablet cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Mclazide-M Tablet is typically initiated at a low dose; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Mclazide-M Tablet :

Should you forget a Mclazide-M Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid doubling the prescribed amount.

Facts to Know About Mclazide-M Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Mclazide-M Tablet

Mclazide-M Tablets combine gliclazide and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with a healthy diet and regular physical activity. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. Mclazide-M is unsuitable for type 1 DM.
Mclazide-M Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Mclazide-M Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Mclazide-M can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare metformin-related side effect is preventable by avoiding use in patients with kidney disease, the elderly, or heavy alcohol consumers. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Mclazide-M and seek immediate medical attention.
Prolonged Mclazide-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance difficulties), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Mclazide-M Tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol while taking Mclazide-M tablets is unsafe. This combination can worsen hypoglycemia and raise the risk of lactic acidosis.
Mclazide-M Tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Mclazide-M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Yes, Mclazide-M Tablets can lower blood sugar, causing hypoglycemia. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and shakiness or anxiety. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Mclazide-M Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Mclazide-M immediately and seek medical attention.
Prolonged Mclazide-M Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Patients with known allergies to Mclazide-M Tablet components or excipients, moderate-to-severe kidney disease, or underlying metabolic acidosis (including diabetic ketoacidosis) should not use this medication.
Combining Mclazide-M tablets and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Mclazide-M Tablet
53
MRP 64
17% off